Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Charlottesville, Virginia
- Most recent report
- 8-K, filed Aug 25, 2026
- Incorporated
- Delaware
- Filings on record
- 555 filings
- On EDGAR
- CIK 1513525
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 34
News 8 of 151
- 8-K Current report on a material event Aug 25, 2026
- 8-K Current report on a material event Aug 21, 2026
- 8-K Quarterly results Aug 17, 2026
- 8-K Leadership change Aug 13, 2026
- 8-K/A Current report on a material event, amended Aug 11, 2026
- 8-K Leadership change Jun 11, 2026
- 8-K Quarterly results May 11, 2026
- 8-K Leadership change Apr 9, 2026
Prospectuses and Registrations 8 of 87
- S-3 Shelf registration statement Aug 28, 2026
- S-8 Registration statement for an employee plan Aug 28, 2026
- 424B5 Prospectus supplement for an offering Dec 19, 2025
- S-3 Shelf registration statement Dec 12, 2025
- S-8 Registration statement for an employee plan Sep 9, 2025
- 424B5 Prospectus supplement for an offering Aug 1, 2025
- 424B5 Prospectus supplement for an offering Jul 31, 2025
- 424B5 Prospectus supplement for an offering Jun 18, 2025
Proxies 8 of 21
- DEF 14A Proxy statement for a shareholder vote Aug 24, 2026
- PRE 14A Preliminary proxy statement Aug 11, 2026
- DEF 14A Proxy statement for a shareholder vote Jan 6, 2026
- PRE 14A Preliminary proxy statement Dec 23, 2025
- DEFR14A Jun 27, 2025
- DEF 14A Proxy statement for a shareholder vote Jun 10, 2025
- PRE 14A Preliminary proxy statement May 23, 2025
- DEF 14A Proxy statement for a shareholder vote Sep 27, 2024
Ownership 8 of 138
- 4 Insider reported a trade Jul 16, 2026
- 4 Insider reported a trade Jul 13, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 1, 2026
- 4 Insider reported a trade Jul 1, 2026
- 3 Insider reported their initial holding Jun 29, 2026
- SCHEDULE 13G Large holder reported a passive stake Jun 24, 2026
- 4 Insider reported a trade Jun 16, 2026
- 3 Insider reported their initial holding Jun 16, 2026
Other 8 of 124
- ARS Annual report sent to shareholders Aug 24, 2026
- EFFECT Notice that a registration became effective Dec 17, 2025
- CORRESP Reply to SEC staff Dec 15, 2025
- D Dec 3, 2025
- PRER14A Jun 17, 2025
- EFFECT Notice that a registration became effective Jun 16, 2025
- CORRESP Reply to SEC staff Jun 12, 2025
- CORRESP Reply to SEC staff Jun 12, 2025
Everything here comes from Adial Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.